Cusp Overlap for Higher CoreValve Implantation

Implant depth greater than the length of the membranous septum is an independent predictor of permanent pacemaker implantation. Valve implantation 3 to 5 mm below the aortic annulus in a projection coaxial to the device is recommended. The problem is this is rarely in the annular plane of the valve.

Cirugía para mejorar la sobrevida en insuficiencia tricuspidea aislada

Ideal annular plane projection is normally suggested by CT. For CoreValves, correction of parallax was achieved by adding right anterior oblique caudal angulation, which preserves the anatomic annular plane of the native valve and produces an overlap of right and left coronary cusps (cusp overlap).

This differs from manufacturer recommendation to use left anterior oblique angulation. This produces a shallower apparent device depth of 1 to 2 mm.

This technique could enable higher implantation, making the self-expandable valve more competitive in terms of conduction, vs balloon expandable valves. 

The risk of excessively higher implantation with this technique might increase paravalvular regurgitation, or even embolization.  


Read also: Should Total Occlusion Influence on Revascularization Strategy?


Small observational studies on cusp overlap have shown permanent pacemaker implantation rate lower than 5% for CoreValve and no significant increase in leak or device embolization. 

Implantation 3 to 5 mm below the aortic annulus, using a radiographic projection chosen for both the valve and the device can help improve permanent pacemaker implantation rate. 

This should be confirmed by multicenter registries, with special attention to low-risk population. 

Original Title Low Rates of Permanent Pacing Are Observed Following Self-Expanding Transcatheter Aortic Valve Replacement Using an Annular Plane Projection for Deployment.

Reference: Anthony D. Pisaniello et al. Circ Cardiovasc Interv. 2021;14:e009258. DOI: 10.1161/CIRCINTERVENTIONS.120.009258.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

EARLY TAVR: Impact of Age on Outcomes of Early TAVR in Asymptomatic Patients

Asymptomatic severe aortic stenosis represents an increasingly common clinical challenge. Although current guidelines recommend intervention once symptoms develop or left ventricular dysfunction occurs, concerns...

T-TEER: Beyond Traditional Pulmonary Hypertension Thresholds

Significant tricuspid regurgitation (TR) is associated with progressive functional deterioration, heart failure (HF) hospitalizations, and increased mortality. In recent years, transcatheter tricuspid edge-to-edge repair...

Is left atrial appendage closure safe in patients with reduced ejection fraction?

Patients with heart failure with reduced ejection fraction (HFrEF) were excluded from the major randomized trials evaluating percutaneous left atrial appendage closure (LAAC), and...

Left Atrial Appendage Closure in Spain: Sustained Growth and Favorable Real-World Outcomes

Oral anticoagulation remains the standard treatment for stroke prevention in patients with atrial fibrillation. However, many patients have a high bleeding risk or contraindications...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

EARLY TAVR: Impact of Age on Outcomes of Early TAVR in Asymptomatic Patients

Asymptomatic severe aortic stenosis represents an increasingly common clinical challenge. Although current guidelines recommend intervention once symptoms develop or left ventricular dysfunction occurs, concerns...

Plaque Ruptures in Non-Culprit Arteries: Follow-Up With Intravascular Imaging

Plaque rupture remains one of the most important pathophysiological mechanisms in acute coronary syndromes. However, not all ruptures manifest clinically as ischemia, myocardial infarction,...

Drug-Eluting Stents in Peripheral Arterial Disease: When Should They Be Used?

Peripheral drug-eluting stents have transformed the treatment of peripheral arterial disease by reducing restenosis rates and the need for repeat interventions. However, the emergence...